Scientists identify aggressive pancreatic cancer cells and their vulnerability
Thursday, February 9, 2017 - 15:32
in Health & Medicine
A series of preclinical experiments using patient-derived tumor xenografts (PDXs) and mouse models point to potential treatments for patients with a rapidly-progressing and resistant subgroup of tumor cells.